Literature DB >> 1293401

Quantitation of cinnamaldehyde and cinnamic acid in blood by HPLC.

J Yuan1, J R Bucher, T J Goehl, M P Dieter, C W Jameson.   

Abstract

A rapid and sensitive high performance liquid chromatographic (HPLC) method is described for the quantitation of cinnamaldehyde (CNMA) in rat blood at concentrations of 0.1-100 micrograms/mL. One of the metabolites of CNMA, cinnamic acid, can also be quantified simultaneously. CNMA is unstable in rat blood, probably because of rapid oxidation to cinnamic acid by enzymatic catalysis and nonenzymatic Schiff base formation with free amine groups of blood proteins. The disappearance of CNMA from rat blood follows first-order reaction kinetics with a half-life of 9 min at room temperature. The current analysis method involves the addition of an agent that will prevent CNMA degradation by denaturing protein and competitively blocking nucleophilic addition reactions, resulting in the nearly complete recovery of CNMA from blood. Recovery of cinnamic acid was approximately 80% at concentrations of 1-10 micrograms/mL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293401     DOI: 10.1093/jat/16.6.359

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Cinnamaldehyde Derivatives Inhibit Coxsackievirus B3-Induced Viral Myocarditis.

Authors:  Xiao-Qiang Li; Xiao-Xiao Liu; Xue-Ying Wang; Yan-Hua Xie; Qian Yang; Xin-Xin Liu; Yuan-Yuan Ding; Wei Cao; Si-Wang Wang
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

2.  Textural, Sensory and Volatile Compounds Analyses in Formulations of Sausages Analogue Elaborated with Edible Mushrooms and Soy Protein Isolate as Meat Substitute.

Authors:  Xinyue Yuan; Wei Jiang; Dianwei Zhang; Huilin Liu; Baoguo Sun
Journal:  Foods       Date:  2021-12-27

Review 3.  The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases.

Authors:  Li Lu; Yuan Xiong; Juan Zhou; Guangji Wang; Bobin Mi; Guohui Liu
Journal:  Oxid Med Cell Longev       Date:  2022-10-08       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.